BBI - Brickell Biotech GAAP EPS of -$0.01 beats by $1.43 revenue of $4.32M beats by $1.18M
- Brickell Biotech press release ( NASDAQ: BBI ): Q2 GAAP EPS of -$0.01 beats by $1.43 .
- Revenue of $4.32M (+2780.0% Y/Y) beats by $1.18M .
- The Company expects its cash and cash equivalents as of June 30, 2022, combined with $2.0 million from expected near-term payments under the APA with Botanix, will support its operations for at least the next 12 months.
For further details see:
Brickell Biotech GAAP EPS of -$0.01 beats by $1.43, revenue of $4.32M beats by $1.18M